Inhaled Nitric Oxide Delivery Systems Market Size, Share & Trends Analysis Report By Type (Pediatric, Adult), By Application (HRF, AHRF), By Product (Disposables, Systems), By End Use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Inhaled Nitric Oxide Delivery Systems Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Inhaled Nitric Oxide Delivery Systems Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Inhaled Nitric Oxide Delivery Systems Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Inhaled Nitric Oxide Delivery Systems Market: Type Movement Analysis, USD Million, 2023 & 2030
4.3. Pediatric
4.3.1. Pediatric Inhaled Nitric Oxide Delivery Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Adult
4.4.1. Adult Inhaled Nitric Oxide Delivery Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Inhaled Nitric Oxide Delivery Systems Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Inhaled Nitric Oxide Delivery Systems Market: Application Movement Analysis, USD Million, 2023 & 2030
5.3. Hypoxic Respiratory Failure (HRF)
5.3.1. Hypoxic Respiratory Failure (HRF) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Adult Respiratory Distress Syndrome (ARDS)
5.4.1. Adult Respiratory Distress Syndrome (ARDS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Inhaled Nitric Oxide Delivery Systems Market: Product Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Inhaled Nitric Oxide Delivery Systems Market: Product Movement Analysis, USD Million, 2023 & 2030
6.3. System
6.3.1. System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Disposables
6.4.1. Disposables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Inhaled Nitric Oxide Delivery Systems Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Inhaled Nitric Oxide Delivery Systems Market: End Use Movement Analysis, USD Million, 2023 & 2030
7.3. Hospitals
7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Ambulatory Centers
7.4.1. Ambulatory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Clinics
7.5.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Inhaled Nitric Oxide Delivery Systems Market: Regional Estimates & Trend Analysis
8.1. Inhaled Nitric Oxide Delivery Systems Market Share, By Region, 2023 & 2030, USD Million
8.2. North America
8.2.1. North America Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. China
8.4.2.1. China Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. India
8.4.3.1. India Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. Japan
8.4.4.1. Japan Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. South Korea Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Thailand Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Australia
8.4.7.1. Australia Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Inhaled Nitric Oxide Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Mallinckrodt Pharmaceuticals
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Getinge AB
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. VERO Biotech
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Linde plc
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Beyond Air, Inc.
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. SLE Ltd.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Bellerophon Therapeutics
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Air Liquide Healthcare
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Circassia Pharmaceuticals
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. International Biomedical
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives